According to Clinical Trials Today, Canadian contract research organization (CRO) ASKA Research entered into strategic partnerships with two CROs that will expand ASKA’s service offerings in North America and in Australia.
The first partnership, with Queensland, Australia-based Clinical Network Services (CNS), was made possible by the Economic Research Agreement between British Columbia and Queensland, which went into effect last June. The agreement is designed to build international relations in key sectors, such as biotechnology and life sciences.
According to ASKA, the partnership with CNS is the first business-to-business partnership resulting from the intergovernmental alliance.
ASKA also entered into a partnership with Winnipeg, Canada-based Clinical Development Solutions (CDS), which focuses on cardiovascular and metabolic disease areas. ASKA and CDS will provide services to one another and their clients to reduce the time to market and production costs.
With ASKA's partnerships going global, will we see a ripple effect from other CROs?
About:
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is an extension of the Partnerships in Clinical Trials Conference.
As a reader of the Partnerships in Clinical Trials blog, mention code XP1718BLOG when registering to join us in Sao Paulo for Partnerships in Clinical Trials Latin America to receive a discount of $100 off the current rate!
Would you like to guest blog on our site? Or send us feedback? Send an email to jpereira@iirusa.com.



.gif)
0 comments:
Post a Comment